IMUX
#3592
Immunic, Inc. - Common Stock
15.4 0 USD
-0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.52%
Monthly Change
+18.46%
6 month change
+1455.56%
Year Change
+1778.05%
Previous Close
16.3 0
Open
15.4 0
Low
15.4 0
High
15.4 0
Volume
6
Financials
- Market Capitalization 210.12 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.86
Price to sales ratio
-167.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3589 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 10.91 USD | -1.98% | +6.96% | +22.58% | -34.28% | 211.01 M USD | ||
| 3591 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 5.58 USD | -2.79% | -4.12% | +10.93% | +398.21% | 210.57 M USD | ||
| 3594 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.03 USD | -1.37% | +4.57% | +25.75% | +135.05% | 209.23 M USD | ||
| 3596 |  IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +27.43% | +7.21% | 208.99 M USD |
Frequently asked questions about Immunic, Inc. Common Stock
What is the Immunic, Inc. Common Stock stock price today?
The current price of Immunic, Inc. Common Stock (IMUX) is 15.40. Over the past 24 hours, the stock has changed by -5.52%. Follow the IMUX chart for real-time price dynamics.
What is the stock ticker of Immunic, Inc. Common Stock?
Immunic, Inc. Common Stock trades under the ticker IMUX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunic, Inc. Common Stock stock going up?
IMUX has changed by -6.55% over the last week, +18.46% over the last month, and +1778.05% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immunic, Inc. Common Stock?
Immunic, Inc. Common Stock currently has a market capitalization of 210.12 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immunic, Inc. Common Stock earnings last quarter?
Last quarter, Immunic, Inc. Common Stock reported earnings of -0.8 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immunic, Inc. Common Stock revenue for the last quarter?
Immunic, Inc. Common Stock reported quarterly revenue of -209 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Immunic, Inc. Common Stock net income for the last quarter?
Immunic, Inc. Common Stock reported net income of -34.1 M for the last quarter. The previous quarter showed -32.59 M, which means net income changed by -4.64%.
Is Immunic, Inc. Common Stock a good dividend stock?
Immunic, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Immunic, Inc. Common Stock have?
As of the latest available data, Immunic, Inc. Common Stock has 95 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immunic, Inc. Common Stock stock?
You can buy Immunic, Inc. Common Stock (IMUX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunic, Inc. Common Stock stock?
Investing in Immunic, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMUX chart and related analysis on metatrader.com as part of your research.